N-(1-Methyl-1H-pyrazol-3-yl)-4-phenoxybutanamide

ID: ALA4553355

PubChem CID: 31845722

Max Phase: Preclinical

Molecular Formula: C14H17N3O2

Molecular Weight: 259.31

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ccc(NC(=O)CCCOc2ccccc2)n1

Standard InChI:  InChI=1S/C14H17N3O2/c1-17-10-9-13(16-17)15-14(18)8-5-11-19-12-6-3-2-4-7-12/h2-4,6-7,9-10H,5,8,11H2,1H3,(H,15,16,18)

Standard InChI Key:  JVTPSPSGEKTOST-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
    9.1940  -28.1807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1929  -29.0002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9009  -29.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6106  -28.9997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6078  -28.1771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8992  -27.7718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4862  -27.7723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7786  -28.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0708  -27.7726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3632  -28.1814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6554  -27.7729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9478  -28.1817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6552  -26.9557    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2400  -27.7733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1533  -26.9622    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3539  -26.7925    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9454  -27.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4925  -28.1074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0213  -26.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 16 19  1  0
M  END

Alternative Forms

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

tat Human immunodeficiency virus type 1 Tat protein (1183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 259.31Molecular Weight (Monoisotopic): 259.1321AlogP: 2.22#Rotatable Bonds: 6
Polar Surface Area: 56.15Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.37CX Basic pKa: 1.20CX LogP: 2.28CX LogD: 2.28
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.81Np Likeness Score: -2.00

References

1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE..  (2019)  Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models.,  62  (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462]

Source